Detalhe da pesquisa
1.
Thrombotic and bleeding complications in patients with AL amyloidosis.
Br J Haematol
; 204(5): 1816-1824, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38321638
2.
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance.
Br J Haematol
; 193(1): 113-118, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32829529
3.
Pulmonary function tests reveal unrecognised lung dysfunction and have independent prognostic significance in patients with systemic AL amyloidosis.
Amyloid
; 30(2): 153-160, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36281984
4.
Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.
Int J Cardiol
; 363: 102-110, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716935
5.
Next generation flow cytometry for MRD detection in patients with AL amyloidosis.
Amyloid
; 28(1): 19-23, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783569
6.
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease.
Amyloid
; 28(4): 259-266, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468250
7.
Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study.
Leukemia
; 35(5): 1418-1427, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589757
8.
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis.
Amyloid
; 28(1): 3-11, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32713209
9.
Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications.
Amyloid
; 27(2): 103-110, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971444
10.
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.
Blood Cancer J
; 10(11): 109, 2020 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33149167
11.
Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM.
Clin Lymphoma Myeloma Leuk
; 19(1): 23-28, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224328
12.
Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone.
Blood Adv
; 3(23): 4095-4103, 2019 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31821457
13.
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone.
Blood Adv
; 3(20): 3002-3009, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648323
14.
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis.
Amyloid
; 25(4): 234-241, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663408
15.
Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome.
Hemasphere
; 4(3): e381, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32647800
16.
Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma.
Blood Cancer J
; 10(3): 25, 2020 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123158